Skip to content
User

Appaloosa Management TEVA-OLD trades

David Tepper

David Tepper Teva Pharma Industries Ltd ADR stake

total: 317

Trades details

Total transactions:
3
New positions:
1
Sold out:
1
Reduced:
1
Held since:
2016 Q4
Held for:
2 quarters
Latest activity:
2017 Q2
According to 2026 Q2 report, David Tepper doesn't hold any Teva Pharma Industries Ltd ADR (TEVA-OLD) shares. To date, the estimated cost basis is nearly $36.25 for "buy" trades and estimated average "sell" price is $32.09. Appaloosa Management first purchased TEVA-OLD in 2016 Q4, initially acquiring about 5.05M shares. Since the initial investment in Teva Pharma Industries Ltd ADR (TEVA-OLD), Appaloosa Management has made 2 more transactions.

When did David Tepper sell Teva Pharma Industries Ltd ADR (TEVA-OLD)?

David Tepper sold off the entire Teva Pharma Industries Ltd ADR (TEVA-OLD) position in 2017 Q2.

When did David Tepper buy Teva Pharma Industries Ltd ADR (TEVA-OLD)?

David Tepper first invested in Teva Pharma Industries Ltd ADR (TEVA-OLD) in 2016 Q4 at the reported quarter-end price of $36.25 per share.

What's the cost basis of Appaloosa Management's TEVA-OLD stake?

The estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA-OLD) stake is around $36.25 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$36.25
Weighted AVG sell price:
$32.09

David Tepper's historical trades in Teva Pharma Industries Ltd ADR

3 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2017 Q2
0.00%
$32.09
-100% (-2,175,000)
2017 Q1
1.22%
$32.09
-56.96% (-2,878,000)
2016 Q4
3.38%
$36.25
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.